We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year [Yahoo! Finance]
BioNTech SE - American Depositary Shares (BNTX)
Company Research
Source: Yahoo! Finance
The overall pay is 80% below the industry average Over the past three years, BioNTech's EPS fell by 54% and over the past three years, the total loss to shareholders 52% The underwhelming performance at BioNTech SE NASDAQ:BNTX ) recently has probably not pleased shareholders. The next AGM coming up on 17th of May will be a chance for shareholders to have their concerns addressed by the board, challenge management on company strategy and vote on resolutions such as executive remuneration, which may help change the company's future prospects. We think most shareholders will probably pass the CEO compensation, based on what we gathered. View our latest analysis for BioNTech Comparing BioNTech SE's CEO Compensation With The Industry At the time of writing, our data shows that BioNTech SE has a market capitalization of US$22b, and reported total annual CEO compensation of €3.1m for the year to December 2023. That's a notable decrease of 52% on last year. While this analysis focu
Show less
Read more
Impact Snapshot
Event Time:
BNTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNTX alerts
High impacting BioNTech SE - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
BNTX
News
- BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $113.00 price target on the stock.MarketBeat
- Germany risks becoming ‘developing country', says stock exchange chief [Yahoo! Finance]Yahoo! Finance
- ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours [Yahoo! Finance]Yahoo! Finance
- Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)GlobeNewswire
- NHS launches personalised mRNA cancer vaccines trial [Yahoo! Finance]Yahoo! Finance
BNTX
Earnings
- 5/6/24 - Miss
BNTX
Sec Filings
- 6/3/24 - Form 6-K
- 5/30/24 - Form 6-K
- 5/21/24 - Form 6-K
- BNTX's page on the SEC website